| Literature DB >> 32083387 |
Masanao Yokohira1, Nozomi Hashimoto1, Keiko Yamakawa1, Yuko Nakano-Narusawa1, Yoko Matsuda1, Katsumi Imaida1.
Abstract
This present study was conducted in an attempt to examine proliferative lesion-promoting effect in the lung by compensatory lung growth after left pulmonary ligation. To examine a strong proliferative lesion-promoting effect in the lung, the effects of left pulmonary ligation on lung proliferative lesions induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) were examined for 12 weeks. The number of proliferative lesions induced by NNK in the right lung after left pulmonary ligation increased significantly after 12 weeks, indicated by an increase in the weight of the right lung. In addition, several messenger RNA (mRNA) markers, including insulin growth factor 1, were highly expressed in the right lung on the seventh day after left ligation. These experiments demonstrated the clear proliferative lesion-promoting effects of pulmonary ligation on the induction of the expression of mRNAs related to the cell cycle, cell division and mitosis. However, the proliferative lesion-promoting effects were not strong enough to allow a shortened experimental period for the establishment of the lung bioassay model. The results also indicated the necessity to pay attention to the possibility of a recurrence of lung cancer in the residual lung after resection in humans.Entities:
Keywords: A/J mouse; IGF-1; NNK; ligation; lung proliferative lesion
Mesh:
Substances:
Year: 2020 PMID: 32083387 PMCID: PMC7318118 DOI: 10.1111/pin.12915
Source DB: PubMed Journal: Pathol Int ISSN: 1320-5463 Impact factor: 2.534
Figure 1Design of experiment 1 for testing the effects of left pulmonary ligation to the lung tumor induced by 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK).
Figure 2(a) The schema of the operation. Solid line indicates the location of clipping. (b) Macroscopic finding on week 12 in experiment 1. The left lung (L) appears completely collapsed.
Figure 3Design of experiment 2 for the microarray analysis of the right lung with left pulmonary ligation.
Macroscopical and histopathological lesions in the lung (experiment 1)
| 1 | 2 | |||
|---|---|---|---|---|
| Groups | NNK + Left ligation | NNK + Left sham | ||
| No. | 7 | 15 | ||
| Macroscopic lung nodules | ||||
| Right | 5.4±3.0 | 2.5±2.4 | ||
| Left | 0.0±0.0 | 1.3±2.3 | ||
| Bilateral | 5.4±3.0 | 3.9±4.5 | ||
| Histopathological lung lesions | ||||
| Hyperplasia | ||||
| Right | 2.6±1.7 | 1.2±1.2 | ||
| Left | 0.0±0.0 | 0.4±0.6 | ||
| Bilateral | 2.6±1.7 | 1.6±1.5 | ||
| Adenoma | ||||
| Right | 0.4±0.8 | 0.3±0.5 | ||
| Left | 0.0±0.0 | 0.1±0.4 | ||
| Bilateral | 0.4±0.8 | 0.4±0.5 | ||
| Hyperplasia + adenoma | ||||
| Right | 3.3±1.9 | 1.5±1.4 | ||
| Left | 0.0±0.0 | 0.5±0.6 | ||
| Bilateral | 3.0±1.9 | 2.0±1.4 | ||
P < 0.05 vs. NNK with sham operation group.
Abbreviation: NNK4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone.
Figure 4Relative lung weights in experiment 2. Right lung weights of the group with left ligation increased with time and were similar to the bilateral lung weights of the group with sham operation on day 7.
Top 3 clusters (of 92) showing the upregulation and the 10 highest expressed markers in each cluster (experiment 2)
| Clusters | Function | No. of genes |
| Top 10 genes | Average ratio** |
|---|---|---|---|---|---|
| 1 | Cell cycle | 98 | 1.15E‐57 | cell division cycle 25C (Cdc25c) | 2.665 |
| kell blood group (Kel) | 2.637 | ||||
| microtubule‐associated serine/threonine kinase‐like (Mastl) | 2.438 | ||||
| cytoskeleton‐associated protein 2 (Ckap2) | 2.337 | ||||
| asp (abnormal spindle)‐like, microcephaly associated (Drosophila) (Aspm) | 2.277 | ||||
| kinetochore associated 1 (Kntc1) | 2.147 | ||||
| establishment of sister chromatid cohesion N‐acetyltransferase 2 (Esco2) | 2.142 | ||||
| protein regulator of cytokinesis 1 (Prc1) | 2.081 | ||||
| non‐SMC condensin I complex, subunit G (Ncapg) | 2.036 | ||||
| shugoshin‐like 1 (S. pombe)(Sgol1) | 1.992 | ||||
| cell division cycle 25C (Cdc25c) | 2.665 | ||||
| 2 | Cell division | 69 | 5.99E‐45 | microtubule‐associated serine/threonine kinase‐like (Mastl) | 2.438 |
| asp (abnormal spindle)‐like, microcephaly associated (Drosophila) (Aspm) | 2.277 | ||||
| kinetochore associated 1 (Kntc1) | 2.147 | ||||
| protein regulator of cytokinesis 1 (Prc1) | 2.081 | ||||
| non‐SMC condensin II complex, subunit G2 (Ncapg2) | 2.036 | ||||
| shugoshin‐like 1 (S. pombe) (Sgol1) | 1.992 | ||||
| NUF2, NDC80 kinetochore complex component (Nuf2) | 1.971 | ||||
| centromere protein E (Cenpe) | 1.95 | ||||
| baculoviral IAP repeat‐containing 5 (Birc5) | 1.877 | ||||
| cell division cycle 25C (Cdc25c) | 2.665 | ||||
| 3 | Mitosis | 58 | 2.13E‐42 | microtubule‐associated serine/threonine kinase‐like (Mastl) | 2.438 |
| asp (abnormal spindle)‐like, microcephaly associated (Drosophila) (Aspm) | 2.277 | ||||
| kinetochore associated 1 (Kntc1) | 2.147 | ||||
| non‐SMC condensin II complex, subunit G2 (Ncapg2) | 2.036 | ||||
| shugoshin‐like 1 (S. pombe) (Sgol1) | 1.992 | ||||
| NUF2, NDC80 kinetochore complex component (Nuf2) | 1.971 | ||||
| centromere protein E (Cenpe) | 1.95 | ||||
| baculoviral IAP repeat‐containing 5 (Birc5) | 1.877 | ||||
| cyclin B1 (Ccnb1) | 1.864 | ||||
| cyclin B1 (Ccnb1) | 1.864 |
P < 0.05 (5.0E‐2) was considered to be significant.
Figure 5Immunohistochemistry for IGF‐1 (experiment 1). (a) Insulin growth factor 1 (IGF‐1) expression in the lung adenoma in the right lung (left sham operation). Scale bar: 100 μm; (b) IGF‐1 expression in the lung adenoma in the right lung (left ligation). Scale bar: 100 μm; (c) High magnification of IGF‐1 expression in the lung adenoma in the right lung (left ligation). Scale bar: 20 μm; (d) H.E. section of the lung adenoma in the right lung (left ligation), Scale bar: 100 μm. The strong expression of IGF‐1 was observed in the lung hyperplasia and in the 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK)‐induced adenoma. These findings were observed regardless of left pulmonary ligation.